# Immunexpress, Inc.

- Location (FDA's records): Seattle, WA
- FDA decisions: 3 (2017–2023): 3 510(k) clearances
- Product codes: PRE (3)
- Predicates its devices cite: 2 (1 its own); citations of its devices by later devices: 2 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Brahms GmbH: 1 (https://510kreport.com/company/brahms)

## Firms that cite its devices most
- Inflammatix, Inc.: 1 (https://510kreport.com/company/inflammatix)

## Its most-cited devices
- K203748: SeptiCyte RAPID (2021), cited by 1
- K163260: SeptiCyte LAB (2017), cited by 1

## Recent decisions
- K232095: SeptiCyte RAPID (Dec 15, 2023)
- K203748: SeptiCyte RAPID (Nov 29, 2021)
- K163260: SeptiCyte LAB (Feb 17, 2017)

Source page: https://510kreport.com/company/immunexpress